Integrating quality into the cycle of therapeutic development
- 4 December 2002
- journal article
- guideline
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 40 (11), 1895-1901
- https://doi.org/10.1016/s0735-1097(02)02537-8
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection FractionNew England Journal of Medicine, 2002
- 210-Day follow-up of the RAVEL study: a randomized study with the sirolimus-eluting Bx VELOCITY™ balloon-expandable stent in the treatment of patients with de novo native coronary artery lesionsJournal of the American College of Cardiology, 2002
- Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart FailureNew England Journal of Medicine, 2001
- Considerations in the Evaluation of Surrogate Endpoints in Clinical TrialsControlled Clinical Trials, 2001
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001
- President’s page: integrating the Internet into your practiceJournal of the American College of Cardiology, 1999
- A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 1999
- How Good Is the Quality of Health Care in the United States?The Milbank Quarterly, 1998
- Surrogate End Points in Clinical Trials: Are We Being Misled?Annals of Internal Medicine, 1996
- A Strategy for Quality Assurance in MedicareNew England Journal of Medicine, 1990